Antitumor Activity of the MEK Inhibitor TAK-733 Against Melanoma Cell Lines and Patient-Derived Tumor Explants

The goal of this study was to investigate the activity of the selective MEK 1/2 inhibitor, TAK-733, in both melanoma cell lines and patient-derived melanoma xenograft models. In vitro cell proliferation assays using the SRB assay were conducted to determine TAK-733 potency and melanoma responsivenes...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Cancer Ther
Huvudupphovsmän: Micel, Lindsey N., Tentler, John J., Tan, Aik Choon, Selby, Heather M., Brunkow, Kelsey L., Robertson, Kelli M., Davis, S. Lindsey, Klauck, Peter J., Pitts, Todd M., Gangolli, Esha, Fabrey, Robyn, O'Connell, Shawn M., Vincent, Patrick W., Eckhardt, S. Gail
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4671492/
https://ncbi.nlm.nih.gov/pubmed/25376610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-1012
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk